Collectively, the intricate and context-dependent role of AIM2 in RCC underscores its potential as both a driver of tumorigenesis and a therapeutic target, underscoring further investigation into the mechanisms by which AIM2 modulates RCC biology. Here, AIM2 is linked to renal cell carcinoma.